L&C BIO Co.,LTD (KOSDAQ: 290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
26,000
+300 (1.17%)
Jan 22, 2025, 3:00 PM KST
0.00%
Market Cap 583.00B
Revenue (ttm) 70.03B
Net Income (ttm) -5.96B
Shares Out 22.68M
EPS (ttm) -262.78
PE Ratio n/a
Forward PE n/a
Dividend 50.00 (0.20%)
Ex-Dividend Date Dec 27, 2024
Volume 807,110
Average Volume 193,009
Open 27,000
Previous Close 25,700
Day's Range 24,350 - 27,300
52-Week Range 15,000 - 27,450
Beta 0.37
RSI 62.77
Earnings Date Feb 14, 2025

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2011
Employees 130
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

In 2023, L&C BIO Co.,LTD's revenue was 68.87 billion, an increase of 31.00% compared to the previous year's 52.57 billion. Earnings were 48.36 billion, an increase of 964.24%.

Financial Statements

News

There is no news available yet.